| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30000739 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS30031392 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS44017284 | HTLV-1 | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CD3D |
|---|---|
| DrugBank ID | DB09052 |
| Drug Name | Blinatumomab |
| Target ID | BE0003456 |
| UniProt ID | P04234 |
| Regulation Type | antibody |
| PubMed IDs | 25883042 |
| Citations | Zugmaier G, Klinger M, Schmidt M, Subklewe M: Clinical overview of anti-CD19 BiTE((R)) and ex vivo data from anti-CD33 BiTE((R)) as examples for retargeting T cells in hematologic malignancies. Mol Immunol. 2015 Oct;67(2 Pt A):58-66. doi: 10.1016/j.molimm.2015.02.033. Epub 2015 Apr 13. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1742992 |
